Growth Metrics

TELA Bio (TELA) Gains from Investment Securities (2018 - 2026)

TELA Bio has reported Gains from Investment Securities over the past 8 years, most recently at $53000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 381.82% year-over-year to $53000.0; the TTM value through Dec 2025 reached $569000.0, down 42.17%, while the annual FY2025 figure was $798200.0, 62.33% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $53000.0 at TELA Bio, down from $197811.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $1.7 million in Q4 2021 and troughed at -$49377.0 in Q2 2024.
  • A 5-year average of $467787.4 and a median of $197811.0 in 2025 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: surged 13519.35% in 2021 and later tumbled 723.77% in 2024.
  • Year by year, Gains from Investment Securities stood at $1.7 million in 2021, then tumbled by 99.97% to $530.0 in 2022, then soared by 114994.34% to $610000.0 in 2023, then crashed by 98.2% to $11000.0 in 2024, then skyrocketed by 381.82% to $53000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for TELA at $53000.0 in Q4 2025, $197811.0 in Q3 2025, and $734100.0 in Q2 2025.